What is DuPont's updated full-year adjusted earnings outlook for 2026, and what business units are driving this revision?

DuPont de Nemours Inc. has raised its full-year 2026 adjusted earnings outlook to $7.17 to $7.32 per share, marking its second upward revision of the year; this improvement is explicitly attributed to strong sales growth in its two primary business units—Aerospace and Healthcare.

Why did DuPont revise its 2026 financial outlook upward for the second time in 2026?

DuPont revised its 2026 full-year outlook upward for the second time due to better-than-expected second-quarter results and sustained strong sales growth in its two primary business units—Aerospace and Healthcare—which collectively drove the improved earnings projection of $7.17 to $7.32 per share.

DuPont Raises 2026 Outlook as Aerospace, Healthcare Drive Gains

Aug 4, 2026

DuPont de Nemours Inc. raised its full-year adjusted earnings outlook to $7.17–$7.32 per share, exceeding analyst expectations. The positive revision stems from strong sales growth in aerospace and healthcare segments following better-than-expected Q2 results.

Bloomberg.com

2026-04-20

Natural Antioxidant Market Outlook 2026 | Vitafoods Europe

2026-05-05

DuPont Lifts Outlook, Plans $275 Million Buyback

2026-05-07

The Chemistry of Uncertainty

2026-05-12

Global Specialty Food Ingredients Market Projected for Explosive Growth Through 2033

2026-05-13

DuPont tops estimates, lifts outlook as shares jump